Karakousis C P, Rao U, Moore R
J Surg Oncol. 1985 Jun;29(2):105-11. doi: 10.1002/jso.2930290208.
Thirty-eight patients with adrenal adenocarcinoma were reviewed. Two of 23 males and 8 of 15 females had a functioning tumor (P less than 0.005). The most striking finding in this review was the variation in survival according to histologic grade. The median survival from histologic diagnosis was for grade I tumors 54 months, for grade II tumors 26 months, for grade III tumors 1 month. The difference in survival between patients with grade I or II tumors and those with grade III tumors was significant (P less than 0.001). The majority of the patients with grade III tumors were admitted with clinical evidence of disseminated disease and died within 1 month. Among the patients with well-differentiated tumors, five who received surgical treatment of their recurrence had a median survival of 51 months, whereas seven patients who received no surgical treatment had median survival of 20 months following first recurrence (0.05 less than P less than 0.10).
对38例肾上腺腺癌患者进行了回顾性研究。23例男性患者中有2例、15例女性患者中有8例存在功能性肿瘤(P<0.005)。本次回顾性研究中最显著的发现是生存情况根据组织学分级存在差异。从组织学诊断开始计算的中位生存期,I级肿瘤为54个月,II级肿瘤为26个月,III级肿瘤为1个月。I级或II级肿瘤患者与III级肿瘤患者的生存差异具有显著性(P<0.001)。大多数III级肿瘤患者因播散性疾病的临床证据入院,并在1个月内死亡。在高分化肿瘤患者中,5例接受复发性肿瘤手术治疗的患者中位生存期为51个月,而7例未接受手术治疗的患者在首次复发后的中位生存期为20个月(0.05<P<0.10)。